Synergistic photodynamic and chemodynamic therapy using hypoxia-adaptive Ce6@Co nanoparticles for enhanced tumor suppression

Conventional photodynamic therapy (PDT) is less effective in solid tumors owing to Type-II PDT mechanism's reliance on oxygen (O2), which is scarce in hypoxic environments. Most hydrophobic photosensitizers have poor water solubility, complicating their formulation and delivery. To address thes...

Full description

Saved in:
Bibliographic Details
Main Authors: Yeji Chang, Yong Geun Lim, Kyeongsoon Park
Format: Article
Language:English
Published: Elsevier 2025-12-01
Series:International Journal of Pharmaceutics: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590156725000337
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conventional photodynamic therapy (PDT) is less effective in solid tumors owing to Type-II PDT mechanism's reliance on oxygen (O2), which is scarce in hypoxic environments. Most hydrophobic photosensitizers have poor water solubility, complicating their formulation and delivery. To address these challenges, Ce6@Co nanoparticles (a hypoxia-adaptive nanoplatform) were developed via coordinating Co2+ ions with chlorin e6 (Ce6), exhibiting uniform size (∼230 nm), enhanced dispersibility, and colloidal stability. These nanoparticles generate dual-mode reactive oxygen species (ROS): Type-II 1O2 via PDT under 670 nm irradiation and oxygen-independent hydroxyl radical (⋅OH) via Co2+-mediated Fenton-like reactions. In vitro, Ce6@Co nanoparticles demonstrated superior cellular uptake and robust ROS amplification, and reduced squamous cell carcinoma (SCC7) cell viability to 34.4 % under normoxia and 20.48 % under hypoxia via synergistic photodynamic and chemodynamic (PDT-CDT) effects, causing considerable apoptosis. In vivo, intratumoral administration of Ce6@Co nanoparticles via laser irradiation completely suppressed tumors in SCC7 tumor-bearing mice. This effect was attributed to favorable intratumoral distribution, enhanced retention, and synergistic PDT-CDT. No systemic toxicity was observed, as indicated by stable body weight, normal serum biomarkers, and unchanged organ histology. The Co2+-coordinated photosensitizer system uses hypoxia-elevated H2O2 to sustain CDT, effectively overcoming conventional PDT's oxygen dependence and offering a safe and effective dual-modal therapeutic strategy for hypoxic solid tumors.
ISSN:2590-1567